ANTISERUM TO HUMAN HEMOPEXIN
K-Number: K790713 · 1979-09-04
Advertisement
Device Summary
Frequently Asked Questions
What is the ANTISERUM TO HUMAN HEMOPEXIN?
ANTISERUM TO HUMAN HEMOPEXIN is a medical device that received FDA 510(k) clearance on 1979-09-04. The listed applicant is Kent Laboratories, Inc.. The 510(k) number is K790713.
When did ANTISERUM TO HUMAN HEMOPEXIN receive FDA 510(k) clearance?
ANTISERUM TO HUMAN HEMOPEXIN received FDA 510(k) clearance on 1979-09-04, under 510(k) number K790713.
Who is the listed applicant for ANTISERUM TO HUMAN HEMOPEXIN?
The FDA 510(k) record lists Kent Laboratories, Inc. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for ANTISERUM TO HUMAN HEMOPEXIN?
The FDA product code for ANTISERUM TO HUMAN HEMOPEXIN is CZX.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing Kent Laboratories, Inc. as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: CZX)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.
Advertisement